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Objective: to evaluate the effects of treatment with pro-
tease inhibitors on serum level of triglycerides, choles-
terol and glycemia in HIV-infected patients, in assessing
the need of monitoring patients.
We performed a retrospective study on 25 patients
with HIV infection, in evidence of the Infectious Dis-
eases Hospital of Braşov, treated with protease inhibitors
in the treatment regimen. We studied the levels of cho-
lesterol, serum triglycerides and blood glucose at the
beginning and during treatment with protease inhibitors.
We found increases in serum cholesterol levels in 72%
of patients and in 83.33% of them were increasing by
50% from baseline; growth exceeded baseline in 44.45%
of cases. Serum triglycerides have increased to 68% of
patients, with up to 100% from baseline in 64.5% of
cases and in the rest of the patients the increase was
marked, beyond 100% exceeded normal values in 64.5%
of cases. Blood glucose was maintained at normal levels
in 56% patients and increased in 24% of cases.
Treatment with protease inhibitors is associated fre-
quently with increased serum levels of cholesterol and tri-
glycerides; hyperglycemia has rarely occurred. Patients
treated with protease inhibitors require rigorous monitor-
ing of the metabolism of fats and carbohydrates in order
to establish appropriate treatment for early complications
that may have occurred.
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